HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ StudyIvonne Haffner, Florian Lordick, Dieter Maier et al.|Journal of Clinical Oncology|2021Cited by 124
IMMU-01. IMMUNE PHENOTYPING OF BRAIN METASTASIS PATIENTS IDENTIFIES A DISTINCT DEPLETION AND EXHAUSTION PHENOTYPE OF THE CD4 T CELLS IN BLOOD AND BONE MARROWMerle Reetz, Malte Mohme, Alice Ryba et al.|Neuro-Oncology|2023Cited by 0